Form 4 for OM Outset Medical, Inc.
Accepted 2022-04-04 00:00:00 ET · period of report 2022-04-01 · accession 0001484612-22-000031 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-04-04 | 2022-04-01 | OM | Ahmed Nabeel | CFO | M - OptEx | $9.48 | +300 | 44.7K | +0.7% | +$2,844 |
| DM | 2022-04-04 | 2022-04-01 | OM | Ahmed Nabeel | CFO | S - Sale+OE | $45.19 | -300 | 44.5K | -0.7% | -$13.6K |
| DM | 2022-04-04 | 2022-04-01 | OM | Ahmed Nabeel | CFO | M - OptEx | $0.00 | -300 | 10.3K | -3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-01 | M | A | 100 | $9.48 | 44,589 | D | — | — | |
| 2 | Common | Common Stock | 2022-04-01 | S | D | 200 | $45.19 | 44,489 | D | — | — | |
| 3 | Common | Common Stock | 2022-04-01 | S | D | 100 | $45.19 | 44,489 | D | — | — | |
| 4 | Common | Common Stock | 2022-04-01 | M | A | 200 | $9.48 | 44,689 | D | — | — | |
| 5 | Derivative | Performance Options (right to buy) | 2022-04-01 | M | D | 100 | $0.00 | 10,532 | D | $9.48 · — to 2030-05-26 | 100 Common Stock | (F2) This performance option vested on March 15, 2021, upon meeting the performance measures set forth in the Grant Agreement. |
| 6 | Derivative | Performance Options (right to buy) | 2022-04-01 | M | D | 200 | $0.00 | 10,332 | D | $9.48 · — to 2030-05-26 | 200 Common Stock | (F2) This performance option vested on March 15, 2021, upon meeting the performance measures set forth in the Grant Agreement. |